GL1X · GenesisL1 explorer

MolNFT v1 · #38884 · protein

Crystal structure of the ligand binding domain of the vitamin D nuclear receptor in complex with gemini and a coactivator peptide

2HCD · Vitamin D receptor: “Crystal structure of the ligand binding domain of the vitamin D nuclear receptor in complex with gemini and a…”. X-ray diffraction, 1 ligand (BIV), 2 pockets (best druggability 0.87). MolNFT v1 #38884 on…

PDB
2HCD
Type
protein
Length
249 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Vitamin D receptor; Src-1 from nuclear receptor coactivator 1
UniProt
Q9PTN2, Q15788
Ligands
BIV
Pockets
2 · best druggability 0.87

Structure

x-ray diffraction · 2 distinct chains · 63% helix, 3% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AVitamin D receptorprotein23963% helix, 3% strandQ9PTN2
BSrc-1 from nuclear receptor coactivator 1protein1060% helix, 0% strandQ15788

Ligands and binding sites

  • BIV · 21-nor-9,10-secocholesta-5,7,10(19)-triene-1,3,25-triol, 20-(4-hydroxy-4-methylpentyl)-, (1A,3B,5Z,7E) · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13950.870.9441BIV
21670.470.7628empty

Interfaces

1 interface between chains.

  • A–B · 563 Ų buried · 6 hydrogen bonds · protein-protein

Compared structures

  • 2HCD · Crystal structure of the ligand binding domain of the Vitamin D nuclear receptor in… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9PTN2 · AlphaFold monomer V2.0 prediction for vitamin D3 receptor a (Q9PTN2) · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.